Wednesday, March 30, 2022
7:00PM – 8:30PM ET
This virtual program is at 7:00PM Eastern; 6:00PM Central; 5:00PM Mountain; 4:00PM Pacific
Access the clinical/provider tool kit, poster portal, and additional resources @ http://oncologynurse-ce.com
PROGRAM FEATURES
- Online Personalized Poster Portal
- Interactive, case-based learning environment
FACULTY
Sramila Aithal, MD
Breast Medical Oncologist/Hematologist
Alliance Cancer Specialists, PC
Greater Philadelphia area
Philadelphia, PA
Evelyn Robles-Rodríguez, DNP, APN, AOCN
Director, Outreach, Prevention and Survivorship
MD Anderson Cancer Center at Cooper
Camden, New Jersey
PROGRAM DESCRIPTION
Oncology nurses are in an inherently valuable position to be in the frontline of breast cancer treatment for patients. Given identified gaps and faculty feedback, the instructional design of this program is a multi-pronged educational approach designed for an oncology nursing audience. This initiative consists of a one live virtual symposium that will be recorded and re-broadcast to different regions of the country. Additionally, an enduring online version will be available for 12-months, along with a personalized poster portal. For additional resources, please visit www.oncologynurse-ce.com
LEARNING OBJECTIVES
After completing the CME activity, learners should be better able to:
- Evaluate patient education strategies to enhance adherence and persistence to treatment with oral oncolytic therapies in the setting of HR+/HER2- BC
- Discuss the importance of side effect monitoring, recognition, management, and patient education in enhancing patient quality of life and treatment persistence in HR+/HER2- BC treated with oral oncolytics
- Optimize nursing strategies for optimal communication, patient care coordination, and multidisciplinary care team collaboration
TARGET AUDIENCE
This activity is intended for frontline US-based oncology nurses, oncologists, advanced practice clinicians, and pharmacists caring for patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer.
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSING CREDIT INFORMATION
This program would be beneficial for nurses involved in caring for patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing professional education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.5 contact hour of continuing nursing education of RNs and APNs.
ONCC RECERTIFICATION POINTS
The program content has been reviewed by Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
